{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:51:58Z","timestamp":1792144318390,"version":"4.4.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["838576"],"award-info":[{"award-number":["838576"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1195830"],"award-info":[{"award-number":["1195830"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Rapid Eye Movement sleep behavior disorder (RBD) is a parasomnia causing sufferers to physically act out their dreams. These behaviors can disrupt sleep and sometimes lead to injuries in patients and their bed-partners. Clonazepam and melatonin are the first-line pharmacological treatment options for RBD based on direct uncontrolled clinical observations and very limited double-blind placebo-controlled trials. Given the risk for adverse outcomes, especially in older adults, it is of great importance to assess the existing level of evidence for the use of these treatments. In this update, we therefore critically review the clinical and scientific evidence on the pharmacological management of RBD in people aged over 50. We focus on the first-line treatments, and provide an overview of all other alternative pharmacological agents trialed for RBD we could locate as supplementary materials. By amalgamating all clinical observations, our update shows that 66.7% of 1,026 RBD patients reported improvements from clonazepam and 32.9% of 137 RBD patients reported improvements from melatonin treatment on various outcome measures in published accounts. Recently, however, three relatively small randomized placebo-controlled trials did not find these agents to be superior to placebo. Given clonazepam and melatonin are clinically assumed to majorly modify or eliminate RBD in nearly all patients\u2014there is an urgent need to test whether this magnitude of treatment effect remains intact in larger placebo-controlled trials.<\/jats:p>","DOI":"10.1007\/s00415-020-10353-0","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T11:09:30Z","timestamp":1610017770000},"page":"125-148","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["A critical review of the pharmacological treatment of REM sleep behavior disorder in adults: time for more and larger randomized placebo-controlled trials"],"prefix":"10.1007","volume":"269","author":[{"given":"Moran","family":"Gilat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel S.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dries","family":"Testelmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertien","family":"Buyse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J. G.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"key":"10353_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41572-018-0016-5","volume":"4","author":"Y Dauvilliers","year":"2018","unstructured":"Dauvilliers Y, Schenck CH, Postuma RB et al (2018) REM sleep behaviour disorder. Nat Rev Dis Primers 4:19. https:\/\/doi.org\/10.1038\/s41572-018-0016-5","journal-title":"Nat Rev Dis Primers"},{"key":"10353_CR2","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrneurol.2016.152","volume":"12","author":"RB Postuma","year":"2016","unstructured":"Postuma RB, Berg D (2016) Advances in markers of prodromal Parkinson disease. Nat Rev Neurol 12:622\u2013634. https:\/\/doi.org\/10.1038\/nrneurol.2016.152","journal-title":"Nat Rev Neurol"},{"key":"10353_CR3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/nrneurol.2017.157","volume":"14","author":"B H\u00f6gl","year":"2018","unstructured":"H\u00f6gl B, Stefani A, Videnovic A (2018) Idiopathic REM sleep behaviour disorder and neurodegeneration - an update. Nat Rev Neurol 14:40\u201355. https:\/\/doi.org\/10.1038\/nrneurol.2017.157","journal-title":"Nat Rev Neurol"},{"key":"10353_CR4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/sleep\/28.2.203","volume":"28","author":"A Iranzo","year":"2005","unstructured":"Iranzo A, Santamaria J (2005) Severe obstructive sleep apnea\/hypopnea mimicking REM sleep behavior disorder. Sleep 28:203\u2013206. https:\/\/doi.org\/10.1093\/sleep\/28.2.203","journal-title":"Sleep"},{"key":"10353_CR5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.5665\/sleep.5332","volume":"39","author":"A Fern\u00e1ndez-Arcos","year":"2016","unstructured":"Fern\u00e1ndez-Arcos A, Iranzo A, Serradell M et al (2016) The Clinical Phenotype of Idiopathic Rapid Eye Movement Sleep Behavior Disorder at Presentation: A Study in 203 Consecutive Patients. Sleep 39:121\u2013132. https:\/\/doi.org\/10.5665\/sleep.5332","journal-title":"Sleep"},{"key":"10353_CR6","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1176\/ajp.146.9.1166","volume":"146","author":"CH Schenck","year":"1989","unstructured":"Schenck CH, Milner DM, Hurwitz TD et al (1989) A polysomnographic and clinical report on sleep-related injury in 100 adult patients. Am J Psychiatry 146:1166\u20131173. https:\/\/doi.org\/10.1176\/ajp.146.9.1166","journal-title":"Am J Psychiatry"},{"key":"10353_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.5664\/jcsm.27717","volume":"6","author":"RN Aurora","year":"2010","unstructured":"Aurora RN, Zak RS, Maganti RK et al (2010) Best practice guide for the treatment of REM sleep behavior disorder (RBD). J Clin Sleep Med 6:85\u201395","journal-title":"J Clin Sleep Med"},{"key":"10353_CR8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/sleep\/9.2.293","volume":"9","author":"CH Schenck","year":"1986","unstructured":"Schenck CH, Bundlie SR, Ettinger MG, Mahowald MW (1986) Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep 9:293\u2013308. https:\/\/doi.org\/10.1093\/sleep\/9.2.293","journal-title":"Sleep"},{"key":"10353_CR9","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/sleep\/25.2.120","volume":"25","author":"CH Schenck","year":"2002","unstructured":"Schenck CH, Mahowald MW (2002) REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP. Sleep 25:120\u2013138. https:\/\/doi.org\/10.1093\/sleep\/25.2.120","journal-title":"Sleep"},{"key":"10353_CR10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/BF01709881","volume":"17","author":"CH Schenck","year":"1991","unstructured":"Schenck CH, Mahowald MW (1991) Injurious sleep behavior disorders (parasomnias) affecting patients on intensive care units. Intensive Care Med 17:219\u2013224. https:\/\/doi.org\/10.1007\/BF01709881","journal-title":"Intensive Care Med"},{"key":"10353_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.sleep.2012.09.009","volume":"14","author":"R Ferri","year":"2013","unstructured":"Ferri R, Marelli S, Ferini-Strambi L et al (2013) An observational clinical and video-polysomnographic study of the effects of clonazepam in REM sleep behavior disorder. Sleep Med 14:24\u201329. https:\/\/doi.org\/10.1016\/j.sleep.2012.09.009","journal-title":"Sleep Med"},{"key":"10353_CR12","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.sleep.2013.01.007","volume":"14","author":"R Ferri","year":"2013","unstructured":"Ferri R, Zucconi M, Marelli S et al (2013) Effects of long-term use of clonazepam on nonrapid eye movement sleep patterns in rapid eye movement sleep behavior disorder. Sleep Med 14:399\u2013406. https:\/\/doi.org\/10.1016\/j.sleep.2013.01.007","journal-title":"Sleep Med"},{"key":"10353_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1046\/j.1365-2869.1999.00162.x","volume":"8","author":"A Schuld","year":"1999","unstructured":"Schuld A, Kraus T, Haack M et al (1999) Obstructive sleep apnea syndrome induced by clonazepam in a narcoleptic patient with REM-sleep-behavior disorder. J Sleep Res 8:321\u2013322. https:\/\/doi.org\/10.1046\/j.1365-2869.1999.00162.x","journal-title":"J Sleep Res"},{"key":"10353_CR14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000119383","volume":"36","author":"D Kunz","year":"1997","unstructured":"Kunz D, Bes F (1997) Melatonin effects in a patient with severe REM sleep behavior disorder: case report and theoretical considerations. Neuropsychobiology 36:211\u2013214. https:\/\/doi.org\/10.1159\/000119383","journal-title":"Neuropsychobiology"},{"key":"10353_CR15","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/1531-8257(199905)14:3<507::AID-MDS1021>3.0.CO;2-8","volume":"14","author":"D Kunz","year":"1999","unstructured":"Kunz D, Bes F (1999) Melatonin as a therapy in REM sleep behavior disorder patients: an open-labeled pilot study on the possible influence of melatonin on REM-sleep regulation. Mov Disord 14:507\u2013511","journal-title":"Mov Disord"},{"key":"10353_CR16","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/j.1365-2869.2010.00848.x","volume":"19","author":"D Kunz","year":"2010","unstructured":"Kunz D, Mahlberg R (2010) A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder. J Sleep Res 19:591\u2013596. https:\/\/doi.org\/10.1111\/j.1365-2869.2010.00848.x","journal-title":"J Sleep Res"},{"key":"10353_CR17","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1159\/000488893","volume":"76","author":"D Kunz","year":"2017","unstructured":"Kunz D, Bes F (2017) Twenty Years After: Another Case Report of Melatonin Effects on REM Sleep Behavior Disorder, Using Serial Dopamine Transporter Imaging. Neuropsychobiology 76:100\u2013104. https:\/\/doi.org\/10.1159\/000488893","journal-title":"Neuropsychobiology"},{"key":"10353_CR18","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.2174\/1567205014666170523094938","volume":"14","author":"C Schaefer","year":"2017","unstructured":"Schaefer C, Kunz D, Bes F (2017) Melatonin Effects in REM Sleep Behavior Disorder Associated with Obstructive Sleep Apnea Syndrome: A Case Series. Curr Alzheimer Res 14:1084\u20131089. https:\/\/doi.org\/10.2174\/1567205014666170523094938","journal-title":"Curr Alzheimer Res"},{"key":"10353_CR19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.smrv.2016.06.005","volume":"34","author":"F Auld","year":"2017","unstructured":"Auld F, Maschauer EL, Morrison I et al (2017) Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders. Sleep Med Rev 34:10\u201322. https:\/\/doi.org\/10.1016\/j.smrv.2016.06.005","journal-title":"Sleep Med Rev"},{"key":"10353_CR20","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.sleep.2013.05.004","volume":"14","author":"D Kunz","year":"2013","unstructured":"Kunz D (2013) Melatonin in rapid eye movement sleep behavior disorder: why does it work? Sleep Med 14:705\u2013706. https:\/\/doi.org\/10.1016\/j.sleep.2013.05.004","journal-title":"Sleep Med"},{"key":"10353_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.nbscr.2016.11.001","volume":"2","author":"A Videnovic","year":"2017","unstructured":"Videnovic A, Golombek D (2017) Circadian Dysregulation in Parkinson\u2019s Disease. Neurobiol Sleep Circadian Rhythms 2:53\u201358. https:\/\/doi.org\/10.1016\/j.nbscr.2016.11.001","journal-title":"Neurobiol Sleep Circadian Rhythms"},{"key":"10353_CR22","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1001\/jamaneurol.2013.6239","volume":"71","author":"A Videnovic","year":"2014","unstructured":"Videnovic A, Noble C, Reid KJ et al (2014) Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease. JAMA Neurol 71:463\u2013469. https:\/\/doi.org\/10.1001\/jamaneurol.2013.6239","journal-title":"JAMA Neurol"},{"key":"10353_CR23","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.sleep.2013.10.016","volume":"15","author":"SJ Bolitho","year":"2014","unstructured":"Bolitho SJ, Naismith SL, Rajaratnam SMW et al (2014) Disturbances in melatonin secretion and circadian sleep-wake regulation in Parkinson disease. Sleep Med 15:342\u2013347. https:\/\/doi.org\/10.1016\/j.sleep.2013.10.016","journal-title":"Sleep Med"},{"key":"10353_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.sleep.2019.06.001","volume":"63","author":"EH During","year":"2019","unstructured":"During EH, Miglis MG (2019) Clinical trials in REM sleep behavior disorder: an urgent need for better evidence. Sleep Med 63:1\u20132. https:\/\/doi.org\/10.1016\/j.sleep.2019.06.001","journal-title":"Sleep Med"},{"key":"10353_CR25","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1136\/jnnp-2020-322875","volume":"91","author":"A Videnovic","year":"2020","unstructured":"Videnovic A, Ju Y-ES, Arnulf I et al (2020) Clinical trials in REM sleep behavioural disorder: challenges and opportunities. J Neurol Neurosurg Psychiatr 91:740\u2013749. https:\/\/doi.org\/10.1136\/jnnp-2020-322875","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10353_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.sleep.2016.04.014","volume":"32","author":"KK Moghadam","year":"2017","unstructured":"Moghadam KK, Pizza F, Primavera A et al (2017) Sodium oxybate for idiopathic REM sleep behavior disorder: a report on two patients. Sleep Med 32:16\u201321. https:\/\/doi.org\/10.1016\/j.sleep.2016.04.014","journal-title":"Sleep Med"},{"key":"10353_CR27","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/mds.24909","volume":"27","author":"R Di Giacopo","year":"2012","unstructured":"Di Giacopo R, Fasano A, Quaranta D et al (2012) Rivastigmine as alternative treatment for refractory REM behavior disorder in Parkinson\u2019s disease. Mov Disord 27:559\u2013561. https:\/\/doi.org\/10.1002\/mds.24909","journal-title":"Mov Disord"},{"key":"10353_CR28","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2174\/1567205011666140302195648","volume":"11","author":"V Brunetti","year":"2014","unstructured":"Brunetti V, Losurdo A, Testani E et al (2014) Rivastigmine for refractory REM behavior disorder in mild cognitive impairment. Curr Alzheimer Res 11:267\u2013273. https:\/\/doi.org\/10.2174\/1567205011666140302195648","journal-title":"Curr Alzheimer Res"},{"key":"10353_CR29","doi-asserted-by":"publisher","first-page":"235","DOI":"10.5664\/jcsm.27492","volume":"5","author":"KN Anderson","year":"2009","unstructured":"Anderson KN, Shneerson JM (2009) Drug treatment of REM sleep behavior disorder: the use of drug therapies other than clonazepam. J Clin Sleep Med 5:235\u2013239","journal-title":"J Clin Sleep Med"},{"key":"10353_CR30","doi-asserted-by":"crossref","unstructured":"Schenck CH, Montplaisir JY, Frauscher B, et al (2013) Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy--a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group. In: Sleep Med. pp 795\u2013806","DOI":"10.1016\/j.sleep.2013.02.016"},{"key":"10353_CR31","first-page":"33","volume":"16","author":"CR Bamford","year":"1993","unstructured":"Bamford CR (1993) Carbamazepine in REM sleep behavior disorder. Sleep 16:33\u201334","journal-title":"Sleep"},{"key":"10353_CR32","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1212\/wnl.51.2.363","volume":"51","author":"BF Boeve","year":"1998","unstructured":"Boeve BF, Silber MH, Ferman TJ et al (1998) REM sleep behavior disorder and degenerative dementia: an association likely reflecting Lewy body disease. Neurology 51:363\u2013370. https:\/\/doi.org\/10.1212\/wnl.51.2.363","journal-title":"Neurology"},{"key":"10353_CR33","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/j.1479-8425.2006.00212.x","volume":"4","author":"K Yamamoto","year":"2006","unstructured":"Yamamoto K, Uchimura N, Biological MHSA (2006) (2006) Evaluation of the effects of paroxetine in the treatment of REM sleep behavior disorder. Wiley Online Library 4:190\u2013192. https:\/\/doi.org\/10.1111\/j.1479-8425.2006.00212.x","journal-title":"Wiley Online Library"},{"key":"10353_CR34","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/j.pnpbp.2008.06.015","volume":"32","author":"H Shinno","year":"2008","unstructured":"Shinno H, Kamei M, Nakamura Y et al (2008) Successful treatment with Yi-Gan San for rapid eye movement sleep behavior disorder. Prog Neuropsychopharmacol Biol Psychiatry 32:1749\u20131751. https:\/\/doi.org\/10.1016\/j.pnpbp.2008.06.015","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10353_CR35","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.sleep.2007.05.003","volume":"9","author":"T Takahashi","year":"2008","unstructured":"Takahashi T, Mitsuya H, Murata T et al (2008) Opposite effects of SSRIs and tandospirone in the treatment of REM sleep behavior disorder. Sleep Med 9:317\u2013319. https:\/\/doi.org\/10.1016\/j.sleep.2007.05.003","journal-title":"Sleep Med"},{"key":"10353_CR36","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jns.2019.04.029","volume":"401","author":"C Shin","year":"2019","unstructured":"Shin C, Park H, Lee W-W et al (2019) Clonazepam for probable REM sleep behavior disorder in Parkinson\u2019s disease: A randomized placebo-controlled trial. J Neurol Sci 401:81\u201386. https:\/\/doi.org\/10.1016\/j.jns.2019.04.029","journal-title":"J Neurol Sci"},{"key":"10353_CR37","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.sleep.2015.12.020","volume":"21","author":"SX Li","year":"2016","unstructured":"Li SX, Lam SP, Zhang J et al (2016) A prospective, naturalistic follow-up study of treatment outcomes with clonazepam in rapid eye movement sleep behavior disorder. Sleep Med 21:114\u2013120. https:\/\/doi.org\/10.1016\/j.sleep.2015.12.020","journal-title":"Sleep Med"},{"key":"10353_CR38","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1212\/wnl.42.7.1371","volume":"42","author":"O Lapierre","year":"1992","unstructured":"Lapierre O, Montplaisir J (1992) Polysomnographic features of REM sleep behavior disorder: development of a scoring method. Neurology 42:1371\u20131374. https:\/\/doi.org\/10.1212\/wnl.42.7.1371","journal-title":"Neurology"},{"key":"10353_CR39","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1212\/01.wnl.0000168864.97813.e0","volume":"65","author":"A Iranzo","year":"2005","unstructured":"Iranzo A, Santamaria J, Rye DB et al (2005) Characteristics of idiopathic REM sleep behavior disorder and that associated with MSA and PD. Neurology 65:247\u2013252. https:\/\/doi.org\/10.1212\/01.wnl.0000168864.97813.e0","journal-title":"Neurology"},{"key":"10353_CR40","doi-asserted-by":"publisher","first-page":"75","DOI":"10.5664\/jcsm.28044","volume":"7","author":"F Sixel-D\u00f6ring","year":"2011","unstructured":"Sixel-D\u00f6ring F, Schweitzer M, Mollenhauer B, Trenkwalder C (2011) Intraindividual variability of REM sleep behavior disorder in Parkinson\u2019s disease: a comparative assessment using a new REM sleep behavior disorder severity scale (RBDSS) for clinical routine. J Clin Sleep Med 7:75\u201380","journal-title":"J Clin Sleep Med"},{"key":"10353_CR41","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/acn3.753","volume":"6","author":"J-S Jun","year":"2019","unstructured":"Jun J-S, Kim R, Byun J-I et al (2019) Prolonged-release melatonin in patients with idiopathic REM sleep behavior disorder. Ann Clin Transl Neurol 6:716\u2013722. https:\/\/doi.org\/10.1002\/acn3.753","journal-title":"Ann Clin Transl Neurol"},{"key":"10353_CR42","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/mds.27886","volume":"35","author":"M Gilat","year":"2020","unstructured":"Gilat M, Coeytaux Jackson A, Marshall NS et al (2020) Melatonin for rapid eye movement sleep behavior disorder in Parkinson\u2019s disease: A randomised controlled trial. Mov Disord 35:344\u2013349. https:\/\/doi.org\/10.1002\/mds.27886","journal-title":"Mov Disord"},{"key":"10353_CR43","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.sleep.2009.04.007","volume":"10","author":"A Bonakis","year":"2009","unstructured":"Bonakis A, Papageorgiou SG, Merritt S, Williams AJ (2009) REM behaviour disorder preceding palatal tremor. Sleep Med 10:1161\u20131163. https:\/\/doi.org\/10.1016\/j.sleep.2009.04.007","journal-title":"Sleep Med"},{"key":"10353_CR44","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.nrl.2016.11.011","volume":"34","author":"MJ Abenza Abild\u00faa","year":"2019","unstructured":"Abenza Abild\u00faa MJ, Miralles Martinez A, Arpa Guti\u00e9rrez FJ et al (2019) Conditions associated with REM sleep behaviour disorder: Description of a hospital series. Neurologia 34:159\u2013164. https:\/\/doi.org\/10.1016\/j.nrl.2016.11.011","journal-title":"Neurologia"},{"key":"10353_CR45","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1046\/j.1365-2826.2003.00989.x","volume":"15","author":"C Cajochen","year":"2003","unstructured":"Cajochen C, Kr\u00e4uchi K, Wirz-Justice A (2003) Role of melatonin in the regulation of human circadian rhythms and sleep. J Neuroendocrinol 15:432\u2013437. https:\/\/doi.org\/10.1046\/j.1365-2826.2003.00989.x","journal-title":"J Neuroendocrinol"},{"key":"10353_CR46","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1046\/j.1440-1819.2001.00854.x","volume":"55","author":"N Takeuchi","year":"2001","unstructured":"Takeuchi N, Uchimura N, Hashizume Y et al (2001) Melatonin therapy for REM sleep behavior disorder. Psychiatry Clin Neurosci 55:267\u2013269. https:\/\/doi.org\/10.1046\/j.1440-1819.2001.00854.x","journal-title":"Psychiatry Clin Neurosci"},{"key":"10353_CR47","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1002\/gps.2506","volume":"25","author":"V Larsson","year":"2010","unstructured":"Larsson V, Aarsland D, Ballard C et al (2010) The effect of memantine on sleep behaviour in dementia with Lewy bodies and Parkinson\u2019s disease dementia. Int J Geriatr Psychiatry 25:1030\u20131038. https:\/\/doi.org\/10.1002\/gps.2506","journal-title":"Int J Geriatr Psychiatry"},{"key":"10353_CR48","doi-asserted-by":"publisher","first-page":"689","DOI":"10.5664\/jcsm.5796","volume":"12","author":"Y Esaki","year":"2016","unstructured":"Esaki Y, Kitajima T, Koike S et al (2016) An Open-Labeled Trial of Ramelteon in Idiopathic Rapid Eye Movement Sleep Behavior Disorder. J Clin Sleep Med 12:689\u2013693. https:\/\/doi.org\/10.5664\/jcsm.5796","journal-title":"J Clin Sleep Med"},{"key":"10353_CR49","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2169\/internalmedicine.55.5464","volume":"55","author":"K Kashihara","year":"2016","unstructured":"Kashihara K, Nomura T, Maeda T et al (2016) Beneficial Effects of Ramelteon on Rapid Eye Movement Sleep Behavior Disorder Associated with Parkinson\u2019s Disease - Results of a Multicenter Open Trial. Intern Med 55:231\u2013236. https:\/\/doi.org\/10.2169\/internalmedicine.55.5464","journal-title":"Intern Med"},{"key":"10353_CR50","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.5664\/jcsm.6200","volume":"12","author":"Y Wang","year":"2016","unstructured":"Wang Y, Yang Y, Wu H et al (2016) Effects of Rotigotine on REM Sleep Behavior Disorder in Parkinson Disease. J Clin Sleep Med 12:1403\u20131409. https:\/\/doi.org\/10.5664\/jcsm.6200","journal-title":"J Clin Sleep Med"},{"key":"10353_CR51","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1620\/tjem.226.177","volume":"226","author":"T Sasai","year":"2012","unstructured":"Sasai T, Inoue Y, Matsuura M (2012) Effectiveness of pramipexole, a dopamine agonist, on rapid eye movement sleep behavior disorder. Tohoku J Exp Med 226:177\u2013181","journal-title":"Tohoku J Exp Med"},{"key":"10353_CR52","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/WNF.0b013e3181e71166","volume":"33","author":"P Dusek","year":"2010","unstructured":"Dusek P, Bu\u0161kov\u00e1 J, R\u016f\u017ei\u010dka E et al (2010) Effects of ropinirole prolonged-release on sleep disturbances and daytime sleepiness in Parkinson disease. Clin Neuropharmacol 33:186\u2013190. https:\/\/doi.org\/10.1097\/WNF.0b013e3181e71166","journal-title":"Clin Neuropharmacol"},{"key":"10353_CR53","first-page":"1418","volume":"31","author":"H Kumru","year":"2008","unstructured":"Kumru H, Iranzo A, Carrasco E et al (2008) Lack of effects of pramipexole on REM sleep behavior disorder in Parkinson disease. Sleep 31:1418\u20131421","journal-title":"Sleep"},{"key":"10353_CR54","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1212\/wnl.61.10.1418","volume":"61","author":"ML Fantini","year":"2003","unstructured":"Fantini ML, Gagnon J-F, Filipini D, Montplaisir J (2003) The effects of pramipexole in REM sleep behavior disorder. Neurology 61:1418\u20131420. https:\/\/doi.org\/10.1212\/wnl.61.10.1418","journal-title":"Neurology"},{"key":"10353_CR55","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.sleep.2009.06.008","volume":"11","author":"SX Li","year":"2010","unstructured":"Li SX, Wing YK, Lam SP et al (2010) Validation of a new REM sleep behavior disorder questionnaire (RBDQ-HK). Sleep Med 11:43\u201348. https:\/\/doi.org\/10.1016\/j.sleep.2009.06.008","journal-title":"Sleep Med"},{"key":"10353_CR56","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.clineuro.2010.02.011","volume":"112","author":"SL Naismith","year":"2010","unstructured":"Naismith SL, Rogers NL, Mackenzie J et al (2010) The relationship between actigraphically defined sleep disturbance and REM sleep behaviour disorder in Parkinson\u2019s Disease. Clin Neurol Neurosurg 112:420\u2013423. https:\/\/doi.org\/10.1016\/j.clineuro.2010.02.011","journal-title":"Clin Neurol Neurosurg"},{"key":"10353_CR57","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsy053","author":"A Stefani","year":"2018","unstructured":"Stefani A, Heidbreder A, Brandauer E et al (2018) Screening for idiopathic REM sleep behavior disorder: usefulness of actigraphy. Sleep. https:\/\/doi.org\/10.1093\/sleep\/zsy053","journal-title":"Sleep"},{"key":"10353_CR58","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsaa100","author":"M Waser","year":"2020","unstructured":"Waser M, Stefani A, Holzknecht E et al (2020) Automated 3D video analysis of lower limb movements during REM sleep: a new diagnostic tool for isolated REM sleep behavior disorder. Sleep. https:\/\/doi.org\/10.1093\/sleep\/zsaa100","journal-title":"Sleep"},{"key":"10353_CR59","doi-asserted-by":"publisher","first-page":"737","DOI":"10.5664\/jcsm.27032","volume":"3","author":"NA Collop","year":"2007","unstructured":"Collop NA, Anderson WM, Boehlecke B et al (2007) Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. Portable Monitoring Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med 3:737\u2013747","journal-title":"J Clin Sleep Med"},{"key":"10353_CR60","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.smrv.2013.12.002","volume":"18","author":"M Bruyneel","year":"2014","unstructured":"Bruyneel M, Ninane V (2014) Unattended home-based polysomnography for sleep disordered breathing: current concepts and perspectives. Sleep Med Rev 18:341\u2013347. https:\/\/doi.org\/10.1016\/j.smrv.2013.12.002","journal-title":"Sleep Med Rev"},{"key":"10353_CR61","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.ijmedinf.2013.02.008","volume":"82","author":"M Bruyneel","year":"2013","unstructured":"Bruyneel M, Van den Broecke S, Libert W, Ninane V (2013) Real-time attended home-polysomnography with telematic data transmission. Int J Med Inform 82:696\u2013701. https:\/\/doi.org\/10.1016\/j.ijmedinf.2013.02.008","journal-title":"Int J Med Inform"},{"key":"10353_CR62","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.sleep.2015.04.006","volume":"16","author":"M Bruyneel","year":"2015","unstructured":"Bruyneel M, Libert W, Ameye L, Ninane V (2015) Comparison between home and hospital set-up for unattended home-based polysomnography: a prospective randomized study. Sleep Med 16:1434\u20131438. https:\/\/doi.org\/10.1016\/j.sleep.2015.04.006","journal-title":"Sleep Med"},{"key":"10353_CR63","doi-asserted-by":"publisher","first-page":"258418","DOI":"10.1155\/2015\/258418","volume":"2015","author":"P Gros","year":"2015","unstructured":"Gros P, Mery VP, Lafontaine A-L et al (2015) Diagnosis of Obstructive Sleep Apnea in Parkinson\u2019s Disease Patients: Is Unattended Portable Monitoring a Suitable Tool? Parkinsons Dis 2015:258418. https:\/\/doi.org\/10.1155\/2015\/258418","journal-title":"Parkinsons Dis"},{"key":"10353_CR64","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/jsr.12538","volume":"26","author":"H Petersen","year":"2017","unstructured":"Petersen H, Kecklund G, D\u2019Onofrio P et al (2017) Thank god it\u2019s Friday - sleep improved. J Sleep Res 26:567\u2013571. https:\/\/doi.org\/10.1111\/jsr.12538","journal-title":"J Sleep Res"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-10353-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-020-10353-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-10353-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T12:06:50Z","timestamp":1641470810000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-020-10353-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10353"],"URL":"https:\/\/doi.org\/10.1007\/s00415-020-10353-0","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,7]]},"assertion":[{"value":"16 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare to have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}